US Asset Management LLC’s AbbVie ABBV Stock Holding History

US Asset Management LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$967K	Buy	3,842 +37	+1%	+$7.96K	0.74%	32
2026 Q1	$828K	Buy	3,805 +4	+0.1%	+$887	0.72%	37
2025 Q4	$868K	Sell	3,801 -23	-0.6%	-$5.24K	0.71%	36
2025 Q3	$885K	Sell	3,824 -37	-1%	-$7.54K	0.73%	37
2025 Q2	$717K	Sell	3,861 -23	-0.6%	-$4.28K	0.62%	43
2025 Q1	$814K	Hold	3,884	–	–	0.78%	36
2024 Q4	$690K	Sell	3,884 -102	-3%	-$18.8K	0.62%	43
2024 Q3	$679K	Sell	3,986 -89	-2%	-$16.6K	0.6%	49
2024 Q2	$699K	Sell	4,075 -94	-2%	-$15.6K	0.63%	42
2024 Q1	$759K	Sell	4,169 -2,575	-38%	-$444K	0.68%	41
2023 Q4	$1.04M	Buy	+6,744	New	+$983K	1.03%	25
2023 Q2	$899K	Sell	6,675 -359	-5%	-$52.6K	0.95%	29
2023 Q1	$1.12M	Sell	7,034 -52	-0.7%	-$7.95K	1.15%	18
2022 Q4	$1.15M	Buy	+7,086	New	+$1.09M	1.24%	14
2022 Q2	$1.09M	Buy	7,107 +37	+0.5%	+$5.65K	1.2%	15
2022 Q1	$1.15M	Buy	7,070 +57	+0.8%	+$8.28K	1.06%	19
2021 Q4	$950K	Sell	7,013 -61	-0.9%	-$7.21K	0.91%	27
2021 Q3	$763K	Buy	+7,074	New	+$808K	0.74%	37

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

US Asset Management LLC's ABBV Position: Q2 2026 in Review

US Asset Management LLC increased its AbbVie (ABBV) stake by 0.97% in Q2 2026, buying an estimated $7.96K and bringing the position to 3,842 shares worth $967K. The position accounts for 0.74% of the portfolio, ranked #32.

US Asset Management LLC first reported a position in ABBV in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.15M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

US Asset Management LLC held 3,842 shares of AbbVie worth $967K as of Q2 2026.
US Asset Management LLC bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
AbbVie made up 0.74% of US Asset Management LLC's portfolio in Q2 2026, its #32 holding.
US Asset Management LLC first reported a position in AbbVie in Q3 2021 and has held it in 18 quarters since.
US Asset Management LLC's AbbVie position peaked at $1.15M in Q1 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on US Asset Management LLC's 13F filing for Q2 2026, filed 12 Aug 2026.